These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12077046)

  • 1. Discontinuation of thioridazine in patients with learning disabilities: balancing cardiovascular toxicity with adverse consequences of changing drugs.
    Davies SJ; Cooke LB; Moore AG; Potokar J
    BMJ; 2002 Jun; 324(7352):1519-21. PubMed ID: 12077046
    [No Abstract]   [Full Text] [Related]  

  • 2. De novo treatment-resistant psychosis following thioridazine withdrawal.
    Bastiampillai T; Fantasia R; Nelson A
    Aust N Z J Psychiatry; 2014 Jun; 48(6):585-6. PubMed ID: 23908310
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors associated with the successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities.
    Branford D
    J Intellect Disabil Res; 1996 Aug; 40 ( Pt 4)():322-9. PubMed ID: 8884587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Repercussions of the withdrawal of thioridazine].
    Buj Alvarez I; Pifarré Paredero J; Idini E; Puigdevall Ruestes M
    Actas Esp Psiquiatr; 2008; 36(3):183-6. PubMed ID: 18478459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of thioridazine. What happened to thioridazine?
    Arshad P; Morcos M; Sridharan B
    BMJ; 2002 Oct; 325(7370):967. PubMed ID: 12402926
    [No Abstract]   [Full Text] [Related]  

  • 6. Respiratory dyskinesia and dysarthria from prolonged neuroleptic use: tardive dyskinesia?
    Faheem AD; Brightwell DR; Burton GC; Struss A
    Am J Psychiatry; 1982 Apr; 139(4):517-8. PubMed ID: 6121492
    [No Abstract]   [Full Text] [Related]  

  • 7. Thioridazine, drug holidays, and incidence of vomiting.
    Kumar BB
    JAMA; 1978 Jan; 239(1):25. PubMed ID: 579226
    [No Abstract]   [Full Text] [Related]  

  • 8. Sedation effects on responsiveness: evaluating the reduction of antipsychotic medication in people with intellectual disability using a conditional probability approach.
    Smith C; Felce D; Ahmed Z; Fraser WI; Kerr M; Kiernan C; Emerson E; Robertson J; Allen D; Baxter H; Thomas J
    J Intellect Disabil Res; 2002 Sep; 46(Pt 6):464-71. PubMed ID: 12354317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of patients after market withdrawal of thioridazine: a retrospective analysis in a nationwide cohort.
    Purhonen M; Koponen H; Tiihonen J; Tanskanen A
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1227-31. PubMed ID: 22941581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of thioridazine and withdrawal dyskinesias on workshop performance of mentally retarded young adults.
    Breuning SE; Davis VJ; Matson JL; Ferguson DG
    Am J Psychiatry; 1982 Nov; 139(11):1447-54. PubMed ID: 6753612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome, amitriptyline, and thioridazine.
    Corrigan FM; Coulter F
    Biol Psychiatry; 1988 Feb; 23(3):320-1. PubMed ID: 3337866
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged drug-induced Parkinsonism.
    Klawans HL; Bergen D; Bruyn GW
    Confin Neurol; 1973; 35(6):368-77. PubMed ID: 4149771
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiotoxicity and prescription of thioridazine in New Zealand.
    Menkes DB; Knight JC
    Aust N Z J Psychiatry; 2002 Aug; 36(4):492-8. PubMed ID: 12169148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymorphic ventricular tachycardia of torsade de pointes type in patient with schizophrenia treated with thioridazine].
    Sinkiewicz W; Balak W; Fares I; Karasek D; Małyszka P; Papke M
    Pol Arch Med Wewn; 2006 Dec; 116(6):1188-91. PubMed ID: 18634530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thioridazine and the warning about prolonged QT time].
    Laisalmi M
    Duodecim; 2002; 118(24):2518. PubMed ID: 12572286
    [No Abstract]   [Full Text] [Related]  

  • 16. The prolongation of QTc-interval by thioridazine.
    Sachdev P
    Aust N Z J Psychiatry; 2001 Dec; 35(6):857-8. PubMed ID: 11990903
    [No Abstract]   [Full Text] [Related]  

  • 17. Restricting the use of thioridazine.
    Bailey P; Russell V
    Br J Gen Pract; 2002 Jun; 52(479):499-500. PubMed ID: 12051223
    [No Abstract]   [Full Text] [Related]  

  • 18. Photoinduced lichenoid reaction by thioridazine.
    Llambrich A; Lecha M
    Photodermatol Photoimmunol Photomed; 2004 Apr; 20(2):108-9. PubMed ID: 15030597
    [No Abstract]   [Full Text] [Related]  

  • 19. Sudden death in a patient taking antipsychotic drugs.
    Hauben M
    Postgrad Med J; 1999 Feb; 75(880):127. PubMed ID: 10448485
    [No Abstract]   [Full Text] [Related]  

  • 20. Thioridazine cardiotoxicity.
    Hale P; Poklis A
    J Toxicol Clin Toxicol; 1996; 34(1):127-30. PubMed ID: 8632504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.